Eastern Cooperative Oncology Group
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2012-01-01
- Employees
- 51
- Market Cap
- -
- Website
- https://ecog-acrin.org
Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors
- Conditions
- Ovarian CancerTesticular Germ Cell Tumor
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 44
- Registration Number
- NCT00003518
- Locations
- 🇺🇸
CCOP - Kalamazoo, Kalamazoo, Michigan, United States
🇺🇸Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸CCOP - Ochsner, New Orleans, Louisiana, United States
Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 167
- Registration Number
- NCT00003444
- Locations
- 🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸CCOP - Northern New Jersey, Hackensack, New Jersey, United States
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
- Conditions
- Prostate Cancer
- First Posted Date
- 2004-05-24
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00003614
- Locations
- 🇺🇸
CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
High-Dose Methotrexate and Leucovorin in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-05-19
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 36
- Registration Number
- NCT00082797
- Locations
- 🇺🇸
Galesburg Cottage Hospital, Galesburg, Illinois, United States
🇺🇸Rush-Copley Cancer Care Center, Aurora, Illinois, United States
🇺🇸Hubert H. Humphrey Cancer Center at North Memorial Medical Center, Robbinsdale, Minnesota, United States
Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-05-12
- Last Posted Date
- 2023-06-07
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 36
- Registration Number
- NCT00002826
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸Kimball Medical Center, Lakewood, New Jersey, United States
🇺🇸St. Francis Medical Center, Trenton, New Jersey, United States
Combination Chemotherapy in Treating Patients With Bladder Cancer
- Conditions
- Urethral CancerBladder Cancer
- First Posted Date
- 2004-04-23
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 490
- Registration Number
- NCT00003701
- Locations
- 🇺🇸
Hahnemann University Hospital, Philadelphia, Pennsylvania, United States
🇺🇸NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
Interleukin-12 in Treating Patients With Advanced or Recurrent Cancer of the Cervix
- Conditions
- Cervical Cancer
- First Posted Date
- 2004-04-22
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00003017
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸University of Rochester Cancer Center, Rochester, New York, United States
🇺🇸Vanderbilt Cancer Center, Nashville, Tennessee, United States
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
- Conditions
- Head and Neck Cancer
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2023-06-22
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Registration Number
- NCT00003809
- Locations
- 🇺🇸
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
🇺🇸Sylvester Cancer Center, University of Miami, Miami, Florida, United States
🇺🇸Veterans Affairs Medical Center - Indianapolis (Roudebush), Indianapolis, Indiana, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed
- Conditions
- Lung Cancer
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 294
- Registration Number
- NCT00003235
- Locations
- 🇺🇸
St. Francis Medical Center, Trenton, New Jersey, United States
🇺🇸Trinitas Hospital - Jersey Street Campus, Elizabeth, New Jersey, United States
🇺🇸Community Medical Center, Toms River, New Jersey, United States
Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma
- Conditions
- Thymoma and Thymic Carcinoma
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Eastern Cooperative Oncology Group
- Target Recruit Count
- 38
- Registration Number
- NCT00003283
- Locations
- 🇺🇸
CCOP - Kalamazoo, Kalamazoo, Michigan, United States
🇺🇸CCOP - Metro-Minnesota, Saint Louis Park, Minnesota, United States
🇺🇸Ireland Cancer Center, Cleveland, Ohio, United States